Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue in an Intermediate-Risk Patient Population

NCT04972097 is registered in ClinicalTrials.gov with Angiodynamics, Inc. as lead sponsor.

NCT NCT04972097
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04972097 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue in an Intermediate-Risk Patient Population
Lead sponsor
Angiodynamics, Inc.
Phase
Not applicable
Overall status
Completed
Start date
March 29, 2022
Completion date
August 14, 2024
Enrollment
121 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer